GlycoMimetics (GLYC)
(Delayed Data from NSDQ)
$0.26 USD
0.00 (-1.11%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $0.26 0.00 (1.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
GlycoMimetics, Inc. [GLYC]
Reports for Purchase
Showing records 141 - 158 ( 158 total )
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Healthcare - ORD-ARN-JFK: Crossing Our Onco Radar
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Future AML Label Breadth Manifesting; Reiterating Buy - Raising PT to $35
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
The Brave New World of AML
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Through the AML Looking-Glass; Initiating with Buy and $25 PT
Provider: Roth Capital Partners, Inc.